Regulation and legislation

Is CBD here to stay?

8th July 2020 - Presentations , Resources |

This presentation provides an overview of the CBD regulatory change and impact on the market and the change in the number of products by leading brands
Q4 19 vs Q1 20. 

How is the novel food status of CBD progressing in Europe?

3rd July 2020 - Blogs |

Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the  Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.

Regulatory report: Romania, June 2020

30th June 2020 - Regulatory reports |

Pure CBD is not a scheduled substance in Romania. This report examines the current regulatory framework for hemp and CBD in Romania, covering all aspects from import and export to medical and recreational cannabis

What inference can be drawn from the Italian enforcement action against EasyJoint?

11th June 2020 - Blogs |

The suspension of EasyJoint’s commercial activities and website pending a trial in the Italian province of Parma demonstrates that enforcement authorities intend to continue to police CBD retailers. In particular, it seems the Parma prosecutor’s office took exception to the marketing and sale of CBD hemp flowers by EasyJoint. This has significant implications as flowers remain one of the most important CBD categories in the » Continue Reading.

What impact does cannabis have on bankruptcy proceedings?

29th May 2020 - Blogs |

Businesses in the US should be aware of ongoing proceedings in bankruptcy courts related to companies that have been involved in cannabis. Bankruptcy filings and proceedings are unavailable to these companies as it remains an illegal substance at the federal level. This means that businesses forming contracts with companies – even if those companies are only tangentially involved in cannabis – are at risk, » Continue Reading.

What implications can the industry draw from the recent Court of Justice of the European Union (CJEU) opinion in the ongoing French Kanavape case?

15th May 2020 - Blogs |

France cannot stop the import of full spectrum CBD oils extracted from any part of the plant, including flowers, from other EU member states UNLESS it has scientifically established that CBD has psychotropic or toxic effects, and considered whether there were no alternative less-burdensome regulation to an outright ban, according to the opinion from the advocate general of the CJEU, Evgeni Tanchev, that was published yesterday. In sum, French authorities need » Continue Reading.